Clinical Trial Update: Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing dapagliflozin vs pentoxifylline for renoprotective effects in chronic kidney disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Forxiga (dapagliflozin)
• Trental (pentoxifylline)

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Kidney Diseases | Phase 3 | Status: RECRUITING